[ET Net News Agency, 20 January 2025] CMB International raised the target price for WuXi
Bio (02269) to HKD24.24 from HKD22.88 and maintained the "buy" rating.
The research house said it forecasts WuXi Bio's revenue to grow by +7.1%/ +13.4%/ +15.6%
YoY and attributable adj. net income to increase by +0.9%/ +13.0%/ +15.6% YoY in 2024E/
25E/ 26E, respectively. (rc)